SCHEDULE: Meitav Investment Discloses Brainsway Stake

Meitav Investment House Ltd. and its subsidiaries have reported beneficial ownership of 6.31% of Brainsway Ltd.'s ordinary shares.

Summary

• Meitav Investment House Ltd. and its subsidiaries, MEITAV INVESTMENT HOUSE LTD and MEITAV PROVIDENT FUNDS & PENSION LTD, have filed an amendment to their Schedule 13G.
• The filing indicates beneficial ownership of Brainsway Ltd. ordinary shares.
• MEITAV INVESTMENT HOUSE LTD, through its subsidiaries, holds a total of 2,532,352 shares, representing 6.31% of the class.
• MEITAV PROVIDENT FUNDS & PENSION LTD holds 2,069,247 shares, representing 5.16% of the class.
• The total outstanding ordinary shares as of June 01, 2026, were 40,091,644.
• The reporting persons disclaim beneficial ownership in excess of their actual pecuniary interest and deny the existence of a group for Section 13(d) purposes.
• The filing is an amendment to a previous filing, indicating a change in reporting status or holdings.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. It provides factual information about ownership stakes but lacks operational or financial details about the underlying company, Brainsway Ltd.

Positives

• Meitav Investment House Ltd. and its subsidiaries maintain significant holdings in Brainsway Ltd., indicating continued investment interest.
• The reporting entities are clearly identified, providing transparency regarding ownership.

Negatives

• The filing does not contain financial performance data or operational updates for Brainsway Ltd., limiting insight into the company's health.
• The disclaimers regarding group formation and beneficial ownership may obscure the true nature of the relationship between the reporting entities and the shares.

Risks

• The filing does not explicitly mention any risks associated with Brainsway Ltd.'s operations or the investment itself.
• Potential risks could include market volatility affecting the value of Brainsway Ltd. shares, regulatory changes impacting the company, or operational challenges faced by Brainsway Ltd.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding Brainsway Ltd.'s future performance or the reporting persons' future investment strategies.

Management Comments

• Each of the Subsidiaries operates under independent management and makes its own independent voting and investment decisions.
• Neither the filing of this Schedule 13G nor any of its contents shall be deemed to constitute an admission by either the Filing Person or Subsidiaries that a group exists for purposes of Section 13(d) of the Securities Exchange Act of 1934 or for any other purpose, and each reporting person disclaims the existence of any such group.
• The Filing Person and Subsidiaries disclaims any beneficial ownership of the securities covered by this report in excess of their actual pecuniary interest therein.
• This Statement shall not be construed as an admission by the Filing Person or Subsidiaries that they are the beneficial owners of any of the Ordinary Shares covered by this Statement, and each of Filing Person and Subsidiaries disclaims beneficial ownership of any such Ordinary Shares.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors accumulating significant stakes in publicly traded companies. This filing indicates Meitav Investment House Ltd.'s substantial interest in Brainsway Ltd., a company operating in the medical technology sector, potentially signaling confidence or a strategic investment.

Stakeholder Impact

• Shareholders of Brainsway Ltd. may see increased market interest due to the significant stake held by Meitav Investment House Ltd., potentially influencing share price.
• The disclaimers by Meitav Investment House Ltd. regarding group formation and beneficial ownership might raise questions among other stakeholders about the nature of their investment strategy.

Next Steps

• Monitor future filings from Meitav Investment House Ltd. and Brainsway Ltd. for any changes in ownership or company performance.
• Observe Brainsway Ltd.'s operational and financial results to assess the impact of significant institutional holdings.

Key Dates

Keywords

Brainsway Ltd., Schedule 13G, Meitav Investment House Ltd., Meitav Provident Funds & Pension Ltd, Beneficial Ownership, Ordinary Shares, SEC Filing, Investment Holding